Sunday, September 6, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 12, 2026

Citigroup Q4 Earnings on the Deck: How to Approach the Stock Now?

View original at finance.yahoo.com
Citigroup Q4 Earnings on the Deck: How to Approach the Stock Now? Citigroup Inc. C is slated to report fourth-quarter and full-year 2025 results on Jan…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Its earnings outpaced the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 13.19%

    80% confidence
  • The Zacks Consensus Estimate for fourth-quarter sales is pegged at $20.94 billion, indicating a 6.9% year-over-year increase

    80% confidence
  • Management anticipates expenses to be higher than $53.4 billion, including the impacts of FX translation and excluding the goodwill impairment

    80% confidence
  • Branded Cards net credit loss (NCL) is expected to be 3.50-4%

    80% confidence
  • The consensus estimate for earnings for the to-be-reported quarter has been revised downward to $1.65 over the past seven days, indicating a 23.1% rise from the prior-year quarter's actual

    80% confidence
  • Retail Services NCL is expected to be 5.75-6.25%

    80% confidence
  • The company is seeing continued momentum, particularly in M&A

    80% confidence
  • The efficiency ratio is expected to be slightly less than 64%

    80% confidence
  • Management expects IB fees to increase in the mid-20s (percentage) year over year in the fourth quarter

    80% confidence
  • Management expects NII (excluding Markets) to rise 5.5% on a year-over-year basis

    80% confidence
  • Citigroup expects market revenues to be down in the low to mid-single digit in the fourth quarter from a year ago

    80% confidence
  • Citigroup expects revenues to cross $84 billion compared with the prior mentioned $84.1 billion

    80% confidence
  • The transaction is expected to result in a pre-tax loss of $1.2 billion in the fourth quarter of 2025

    80% confidence

Data points we hold from this source

Citigroup Inc. · forward pe ratio11.92 ratio
Citigroup Inc. · non accrual loans3.7 billion_USD
Citigroup Inc. · principal transactions income2.1 billion_USD
Citigroup Inc. · efficiency ratio64 percent
Citigroup Inc. · revenue20.94 billion_USD
Citigroup Inc. · revenue84 billion_USD
Citigroup Inc. · average interest earning assets2.5 trillion_USD
Citigroup Inc. · commissions and fees2.9 billion_USD
Citigroup Inc. · market revenue4.5 billion_USD
Citigroup Inc. · net interest income14.9 billion_USD
Citigroup Inc. · non interest income5.9 billion_USD
Citigroup Inc. · administration and fiduciary fees1.0 billion_USD
Citigroup Inc. · stock repurchase authorization remaining11.3 billion_USD
Citigroup Inc. · dividend per share0.60 USD
Board of Governors of the Federal Reserve System · fed funds rate3.50-3.75 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
Citigroup Q4 Earnings on the Deck: How to Approach the Stock Now? — Source | Via News | Via News